{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:24:26Z","timestamp":1786940666644,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Special Project","award":["25ZDFA005"],"award-info":[{"award-number":["25ZDFA005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06116-w","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:55:03Z","timestamp":1781160903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative continuous vs. interrupted oral anticoagulation in TAVR: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaoqin","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"6116_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pcad.2021.11.003","volume":"69","author":"M Avvedimento","year":"2021","unstructured":"Avvedimento M, Tang GH. L. Transcatheter aortic valve replacement (TAVR): Recent updates[J]. Prog Cardiovasc Dis. 2021;69:73\u201383.","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"6116_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/phar.2056","volume":"38","author":"BA Kalich","year":"2018","unstructured":"Kalich BA, Allender JE, Hollis IB. Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement[J]. Pharmacotherapy. 2018;38(1):122\u201338.","journal-title":"Pharmacotherapy"},{"issue":"Suppl 30","key":"6116_CR3","doi-asserted-by":"publisher","first-page":"S3620","DOI":"10.21037\/jtd.2018.10.59","volume":"10","author":"F McHugh","year":"2018","unstructured":"McHugh F, Ahmed K, Neylon A, Sharif F, Mylotte D. Antithrombotic management after transcatheter aortic valve implantation[J]. J Thorac Dis. 2018;10(Suppl 30):S3620\u20138.","journal-title":"J Thorac Dis"},{"issue":"4","key":"6116_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1160\/TH14-10-0821","volume":"113","author":"VJ van Nijenhuis","year":"2015","unstructured":"Nijenhuis VJ, Bennaghmouch N, van Kuijk JP, ten Capodanno D, Berg JM. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI)[J]. Thromb Haemost. 2015;113(4):674\u201385.","journal-title":"Thromb Haemost"},{"issue":"12","key":"6116_CR5","first-page":"e76434","volume":"16","author":"G Tabowei","year":"2024","unstructured":"Tabowei G, Dadzie SK, Ahzam RM, Rehman MM, Blair K, Habib I, Wei CR, Amin A. Continuation Versus Interruption of Anticoagulation During Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis[J]. Cureus. 2024;16(12):e76434.","journal-title":"Cureus"},{"key":"6116_CR6","doi-asserted-by":"crossref","unstructured":"Jain H, Patel N, Daoud Tariq M, Al-Shammari AS, Khan R, Jain J, Patel R, Ahmed F, Ahmed R, Alexander T. Continued versus interrupted oral anticoagulation during transcatheter aortic valve replacement in patients with atrial fibrillation: a meta-analysis. Am J Ther. 2026;33(1):e31\u20138.","DOI":"10.1097\/MJT.0000000000001979"},{"issue":"5","key":"6116_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1056\/NEJMoa2407794","volume":"392","author":"DJ van Ginkel","year":"2025","unstructured":"van Ginkel DJ, Bor WL, Aarts HM, Dubois C, De Backer O, Rooijakkers MJP, Rosseel L, Veenstra L, van der Kley F, van Bergeijk KH, Van Mieghem NM, Agostoni P, Voskuil M, Schotborgh CE, Jsselmuiden AJJI, Van Der Heyden JAS, Hermanides RS, Barbato E, Mylotte D, Fabris E, Frambach P, Dujardin K, Ferdinande B, Peper J, Bjwm R, Timmers L, Swaans MJ, Brouwer J, Nijenhuis VJ, Overduin DC, Adriaenssens T, Kobari Y, Vriesendorp PA, Montero-Cabezas JM, El Jattari H, Halim J, Van den Branden BJL, Leonora R, Vanderheyden M, Lauterbach M, Wykrzykowska JJ, van \u2018t Hof AWJ, van Royen N, Tijssen J. G. P., Delewi R., Ten Berg J. M. Continuation versus Interruption of Oral Anticoagulation during TAVI. N Engl J Med. 2025;392(5):438\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2407794.","journal-title":"N Engl J Med"},{"key":"6116_CR8","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews[J]. BMJ. 2021;372:n160.","journal-title":"BMJ"},{"key":"6116_CR9","unstructured":"Chandler Jacqueline C, Miranda L, Tianjing, Page Matthew J, Welch VJHW. Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley; 2019;4."},{"issue":"5","key":"6116_CR10","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","volume":"42","author":"AP Kappetein","year":"2012","unstructured":"Kappetein AP, Head SJ, G\u00e9n\u00e9reux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rod\u00e9s-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW. Leon M. B. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)[J]. Eur J Cardiothorac Surg. 2012;42(5):S45\u201360.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"6116_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jcin.2020.09.062","volume":"14","author":"M Brinkert","year":"2021","unstructured":"Brinkert M, Mangner N, Moriyama N, Keller LS, Hagemeyer D, Crusius L, Lehnick D, Kobza R, Abdel-Wahab M, Laine M, Stortecky S, Pilgrim T, Nietlispach F, Ruschitzka F, Thiele H, Linke A, Toggweiler S. Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral Anticoagulants[J]. JACC Cardiovasc Interv. 2021;14(2):135\u201344.","journal-title":"JACC Cardiovasc Interv"},{"key":"6116_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.amjcard.2021.01.042","volume":"147","author":"T Katayama","year":"2021","unstructured":"Katayama T, Yokoyama N, Watanabe Y, Takahashi S, Hioki H, Kawasugi K, Kozuma K. Blood Coagulation Changes With or Without Direct Oral Anticoagulant Therapy Following Transcatheter Aortic Valve Implantation[J]. Am J Cardiol. 2021;147:88\u201393.","journal-title":"Am J Cardiol"},{"issue":"7","key":"6116_CR13","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.amjcard.2018.12.042","volume":"123","author":"N Mangner","year":"2019","unstructured":"Mangner N, Crusius L, Haussig S, Woitek FJ, Kiefer P, Stachel G, Leontyev S, Schlotter F, Spindler A, H\u00f6llriegel R, Hommel J, Thiele H, Borger MA, Holzhey D, Linke A. Continued Versus Interrupted Oral Anticoagulation During Transfemoral Transcatheter Aortic Valve Implantation and Impact of Postoperative Anticoagulant Management on Outcome in Patients With Atrial Fibrillation[J]. Am J Cardiol. 2019;123(7):1134\u201341.","journal-title":"Am J Cardiol"},{"key":"6116_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.amjcard.2021.03.022","volume":"149","author":"AP Tagliari","year":"2021","unstructured":"Tagliari AP, Perez-Camargo D, Ferrari E, Haager PK, J\u00f6rg L, Gennari M, Chen M, Gavazzoni M, Khattab AA, Bl\u00f6chlinger S, Maisano F, Taramasso M. Pre-Operative Continued Oral Anticoagulation Impact on Early Outcomes after Transcatheter Aortic Valve Implantation[J]. Am J Cardiol. 2021;149:64\u201371.","journal-title":"Am J Cardiol"},{"issue":"15","key":"6116_CR15","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.jcin.2021.06.004","volume":"14","author":"D Giacoppo","year":"2021","unstructured":"Giacoppo D. Anticoagulation After Transcatheter Aortic Valve Replacement: Evolving Answers and Still Unaddressed Questions[J]. JACC Cardiovasc Interv. 2021;14(15):1714\u20136.","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"6116_CR16","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.jacc.2017.02.051","volume":"69","author":"R Puri","year":"2017","unstructured":"Puri R, Auffret V, Rod\u00e9s-Cabau J. Bioprosthetic Valve Thrombosis[J]. J Am Coll Cardiol. 2017;69(17):2193\u2013211.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"6116_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jamacardio.2022.1591","volume":"7","author":"TJ Cahill","year":"2022","unstructured":"Cahill TJ, Kirtane AJ, Leon M, Kodali SK. Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement: A Review[J]. JAMA Cardiol. 2022;7(8):866\u201372.","journal-title":"JAMA Cardiol"},{"issue":"20","key":"6116_CR18","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/j.jcin.2021.08.063","volume":"14","author":"D Giacoppo","year":"2021","unstructured":"Giacoppo D. Anticoagulation After Transcatheter Aortic Valve Replacement: Evolving Answers and Still Unaddressed Questions[J]. JACC Cardiovasc Interv. 2021;14(20):2311\u20133.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"6116_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jcin.2020.10.026","volume":"14","author":"V Auffret","year":"2021","unstructured":"Auffret V, Leurent G, Le Breton H. Oral Anticoagulation Continuation Throughout TAVR: High Risk-High Reward or Marginal Gains?[J]. JACC Cardiovasc Interv. 2021;14(2):145\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"6116_CR20","doi-asserted-by":"crossref","unstructured":"Ya\u2019Qoub L, Arnautovic J, Sharkawi M, AlAasnag M, Jneid H. Elgendy I. Y. Antithrombotic management for transcatheter aortic valve implantation. J Clin Med. 2023;12(24):7632.","DOI":"10.3390\/jcm12247632"},{"issue":"3","key":"6116_CR21","doi-asserted-by":"publisher","first-page":"104000","DOI":"10.4330\/wjc.v17.i3.104000","volume":"17","author":"A Goyal","year":"2025","unstructured":"Goyal A, Shoaib A, Fareed A, Jawed S, Khan MT, Salim N, Zameer U, Siddiqui A, Thakur T, Sulaiman SA. Outcomes of periprocedural continuation vs interruption of oral anticoagulation in transcatheter aortic valve replacement[J]. World J Cardiol. 2025;17(3):104000.","journal-title":"World J Cardiol"},{"key":"6116_CR22","doi-asserted-by":"crossref","unstructured":"Khater J, Frazzetto M, Gurgoglione FL, Hasan J, Donelli D, Attizzani G, Cortese B. Peri-procedural continuation versus interruption of anticoagulation for transcatheter aortic valve implantation: a systematic review and meta-analysis. J Clin Med. 2025;14(10):3563.","DOI":"10.3390\/jcm14103563"},{"key":"6116_CR23","doi-asserted-by":"crossref","unstructured":"Borges Martins JM, Dos Santos Borges R, Gosch Berton G, Ferreira Vieira PL, Gomes de Sousa M, Chaves Vieira PA, et al. Continuation versus interruption of oral anticoagulation during TAVI: a systematic review and meta-analysis oral anticoagulation management in TAVI. Catheter Cardiovasc Interv. 2025;106(1):644\u201353.","DOI":"10.1002\/ccd.31599"},{"key":"6116_CR24","first-page":"200575","volume":"29","author":"HA Abdul-Hafez","year":"2026","unstructured":"Abdul-Hafez HA, Awashra A, Ahmad M, Hawawrah AR, Mahafdah B, AbuBaha M, Alazizi I, Shubietah A, Elgendy MS, Emara A. Colchicine therapy in transcatheter aortic valve replacement: Modulating inflammation and outcomes[J]. Int J Cardiol Cardiovasc Risk Prev. 2026;29:200575.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06116-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06116-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06116-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:36:21Z","timestamp":1786937781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06116-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6116"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06116-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"711"}}